Objective: To isolate and characterize bacteria and fungi from acute otitis externa (AOE) and to obtain susceptibility profiles on each bacterial isolate. Study Design: Prospective core series. Methods: Specimens were collected from the external canals of subjects with clinically diagnosed acute otitis externa. Species-level identification for each bacterial isolate recovered was obtained by combining phenotypic and genotypic data. End point mean inhibitory concentration (MIC) testing was performed using National Committee for Clinical Laboratory Standards (NCCLS) recommended methods. Results: In Alconsponsored clinical studies conducted in 1998 to 2000, microbiology specimens were collected from 2039 subjects (2240 diseased ears) by 101 investigators throughout the United States. A total of 2838 bacteria, 32 yeast, and 17 molds were recovered from 2048 ears clinically diagnosed as acute otitis externa. Of the 202 bacterial species recovered, the species most frequently isolated was Pseudomonas aeruginosa (38%). The next 10 species most frequently isolated were: Staphylococcus epidermidis, 9.1%; Staphylococcus aureus, 7.8%; Microbacterium otitidis, 6.6%; Microbacterium alconae, 2.9%; Staphylococcus caprae, 2.6%; Staphylococcus auricularis, 2.0%; Enterococcus faecalis, 1.9%; Enterobacter cloacae, 1.6%; Staphylococcus capitis subsp. Ureolyticus, 1.4%; and Staphylococcus haemolyticus, 1.3%. Susceptibility profiles of S. epidermidis isolates revealed the greatest frequency of highlevel resistance to selected antibiotics (>8 g/mL): 23%, neomycin-resistant; 11%, oxacillin-resistant; and 12%, ofloxacin-resistant. Susceptibility profiles of S. aureus isolates revealed a lower frequency of highlevel resistance: 6.3%, neomycin-resistant; 2.7%, oxacillin-resistant; and 4.5%, ofloxacin-resistant. P. aeruginosa with high-level resistance to quinolones (>128 mcg/mL for ofloxacin) was recovered from only 1 subject. Likewise, resistance of P. aeruginosa to aminoglycosides was rare. Twenty isolates had neomycin MICs >64 mcg/mL and 10 isolates had gentamicin MICs >16 mcg/mL. The coryneform isolates identified as Microbacterium otitidis had an intrinsic lack of susceptibility to quinolones (ofloxacin MICs >16 mcg/mL) and aminoglycosides (tobramycin MICs >32 mcg/mL and gentamicin MICs >8 mcg/mL). Conclusions: Bacterial infections of the external ear canal are most often caused by P. aeruginosa. However, there are a great number of other gram-positive and gram-negative bacterial species that are recovered from patients with acute otitis externa. Because of this diverse etiology, the best topical therapeutic choice for topical therapy is for the most potent, broad-spectrum (especially anti-P. aeruginosa) antibiotic available.
INTRODUCTION
From the time of its initial description by Mayer in 1844 until World War II, acute otitis externa (AOE) was thought to be a fungal infection. 1 Medical attention was focused on AOE during World War II because of its high incidence among troops in the South Pacific. AOE was the second most common reason for lost time from duty among troops stationed in Guam. 2 Nelson noted that 50% to 70% of the caseload for otolaryngologists in the South Pacific was AOE. 3 Investigations initiated during World War II firmly established the bacterial etiology of the disease. 2, 4 Few large-scale studies have been performed since World War II to evaluate the microbiology of AOE. Recently the development of new ototopical antimicrobials for the treatment of infectious ear diseases has reawakened interest in the microbiology of AOE, and large-scale clinical trials have produced an extreme up-to-date database of recovered organisms. New techniques in microbiology permit more exact and detailed analysis of this large group of recovered bacteria.
The object of this study was to determine the microbiology of acute otitis externa by identifying all recovered organisms to the species level and to define the susceptibility profiles of these bacterial isolates to selected antibiotics. These findings are compared with a previously published study of the microbiology of the normal external auditory canal, and the susceptibility profiles of these pathogens are compared with the susceptibility profile of organisms recovered from normal ears. Both of these studies were conducted during the same period of time, 1998 -2000, to provide a benchmark of antibiotic susceptibility for the organisms, which cause this community-acquired infection.
Presented at the Southern Section Meeting of the Triological Society, Captiva Island, FL, January 10 -12, 2002 . In early studies, Pseudomonas was found to be the predominant organism (69%, Senturia; 56%, Perry) 5,6 and the coryneforms (diphtheroids) were the second most frequently isolated organism. While the taxonomy has changed since the 1940s and 1950s and coryneforms have not been identified to the genus or species level, the results of these earlier studies are consistent with more recent literature.
This study was designed to identify each isolate to the species level using phenotypic and genotypic methods, as well as to define the susceptibility profiles of all bacteria isolated against eight commonly used antibiotics. This is the first large-scale microbiologic study of external otitis that has taken advantage of the development of "DNA fingerprinting" to accurately distinguish between different species of bacteria. The technique depends on sampling ribosomal DNA to distinguish between phenotypically identical bacterial organisms.
The microbiologic specimens were obtained as one aspect of several recently conducted clinical trials designed to assess the effectiveness of various ototopical antibiotic agents. To help discriminate between pathogenic and nonpathogenic organisms, a separate study was undertaken to ascertain, again to the species level, the microbiology of the normal external auditory canal.
MATERIALS AND METHODS
Microbiologic external ear canal specimens were collected from 2039 acute otitis externa subjects (2240 diseased ears) by 101 investigators throughout the United States from May 1998 through November 2000. For recovery of bacteria, specimen swabs were used to inoculate thioglycolate broth and three solid media (TSA ϩ 5% sheep blood, chocolate, and MacConkey agar). The inoculated media was incubated for 5 days at 35°C. All isolates recovered were identified to the species level by various phenotypic methodologies: Vitek 32 (bioMerieux, Hazelwood, MO) or Microlog System (Biolog, Inc., Haywood, CA). Genotypic characterization was performed using the RiboPrinter Microbial characterization System (DuPont, Wilmington, DE) and 16S rRNA gene sequencing (MIDI Labs, Inc., Newark, DE). End point MICs were determined using NCCLS-recommended broth microdilution and agar dilution methodologies. 7, 8 PML Microbiologicals (Wilsonville, OR) prepared the microdilution panels used in this study. Corynebacterium isolates were tested using cationadjusted Mueller Hinton Broth supplemented with 10% rabbit serum.
RESULTS
The largest percentages of recovered organisms were gram-negative, but not by much (53%) ( Table I) . A total of 45.3% of all recovered organisms were gram-positive.
Pseudomonas aeruginosa accounted for 71.3% of the gram-negative organisms recovered but for only 37.7% of the total number of isolates. The incidence of P. aeruginosa increased to 50.7% if only those ears were considered from which a single isolate was recovered. Other Pseudomonads, principally a species newly recognized in this study (Pseudomonas otitidis) made up another 2.3% of recovered organisms.
The gram-positive staphylococci were the second most common organisms recovered, accounting for 25% of total isolates. Staphylococcus epidermidis was the most common staphylococcal species recovered (9%), but Staphylococcus aureus was close behind at 7.5%. Seventeen other species of staphylococci were identified.
The second largest groups of gram-positive, pretherapy isolates are members of the coryneform (diphtheroid) bacterial family. Four newly described organisms are identified for the first time in this study. They include Microbacterium species nov. "alconae", "harmoniae," and "otitidis." Together they account for 9.3% of pretherapy isolates. Among ears from which a single isolate was recovered, they account for 11.8% of pretherapy isolates.
Twenty-one species of Enterobacteriaceae and Vibronaceae accounted for 8.5% of recovered organisms, but only 2.7% of single isolates. The most common genera recovered (in descending order of frequency) were Enterobacter, Klebsiella, Serratia, Proteus, and Escherichia coli. No genera accounted for more than 2.7% of total isolates.
Aspergillus and Candida were recovered from only 1.7% of infected ears and were the only fungi or yeast recovered. Fungi and yeast made up less than 1% of single isolates.
Compared with acute otitis media, bacteria are relatively easy to recover in acute otitis externa. The "nogrowth rate" was a mere 7% in the summer and a 13% in the winter. However, because the external auditory canal is not sterile (as the middle ear space ought to be), one cannot always be assured that recovered organisms are pathogens. In comparison to "normal" flora, it is important in sorting pathogens from saprophytic organisms.
With the exception of an apparent peak in the 7-to 12-year-old age group and a decline in incidence among subjects over 50, AOE is evenly distributed across all ages (Table III) .
The well-recognized increase in AOE during the summer months is clearly documented in this study. A total of 80.5% cases occurred during the summer months and 19.5% occurred during the rest of the year (Table III ).
An unexpected finding was a significantly lower incidence of staphylococcus as a pathogen in younger age groups. S. aureus was accounted for in 4% of children under 12 years of age. The incidence rises slightly to 8% in the 13-to 18-year-old age group and then appears to level off. We are unable to account for this observation. Contrary to this, no age-related differences were noticed for Pseudomonas (Table IV) .
Antibiotic susceptibility was recorded for all recovered organisms and is reported in Table III for all strains for which 20 or more isolates were recovered. A distinction is made between the NCCLS "breakpoint" and the breakpoints used to determine the presence of acquired resistance. The NCCLS breakpoints are established to guide therapeutic choices. If low levels of a given antibiotic reach target tissues, the breakpoint will be low even though the organism's "natural" susceptibility to that antibiotic has not changed. "Acquired resistance" refers to an organism's decreased susceptibility to an antibiotic as a result of that organism's exposure-induced adaptation.
One should note that neither of these breakpoints is necessarily relevant to antibiotic selection when topical therapy is used. The high concentrations of antibiotic in topical antibiotic preparations will be lethal to even those organisms with the highest breakpoints, provided the topical solution can penetrate to infected tissues. The resistance patterns in treatment failures were the same as the resistance patterns for clinical cures. Clinical failures must be accounted for by variables other than antimicrobial resistance.
The highest overall level of acquired resistance was seen in staphylococci, especially S. aureus and S. epidermidis, although overall susceptibility remained good even using NCCLS breakpoints. The relatively high level of acquired resistance in certain species of staphylococci has been reported by others and is a reflection of the species' genetic adaptability. The extent of resistance observed in S. epidermis isolated from acute otitis externa subjects is similar to that reported in S. epidermidis isolates from healthy ear canals. 9 The highest level of acquired aminoglycoside resistance was seen in E. coli with Acinetobacter and S. aureus close behind. Gentamicin resistance does not always correlate with resistance to Tobramycin. This is because of the specific aminoglycoside-inactivating enzyme conferring the resistance. An organism may be resistant to one of these drugs but susceptible to the other. Staphylococcus aureus had the highest level of quinolone resistance, but Acinetobacter was a close second.
The relatively low inherent susceptibility to both aminoglycosides and quinolones of the various Microbacterium species, especially "otitides," is noteworthy.
The highest overall incidence of acquired resistance was among the "non-pathogenic" staphylococci, especially S. epidermidis.
DISCUSSION
Since World War II, microbiologic studies of AOE have usually identified P. aeruginosa as the most common causative pathogen and S. aureus as the species second most common, but the relative incidences have varied substantially. The incidences of Pseudomonas has varied from a low 12% to a high of 80% and the incidence of staphylococcus has been reported as low as 8.5% and as high as 29%. 10 -13 Among more recent studies, Jones has reported a 45% incidence of Pseudomonas in adults and a 54% incidence among children.
14 S. aureus accounted for 13% of pretherapy isolates from adults but only 10% from children.
No previous study has reported Microbacterium species as important pathogens in AOE. Microbacterium spe- cies are members of the Corynebacterium group and Corynebacterium species are usually regarded as nonpathogenic saprophytes. They are discarded from studies because they are regarded as normal flora and are consequently, rarely if ever identified to the species level. Three lines of evidence lead us to think these newly recognized species are in fact pathogens: 1) In our previous study of the normal ear canal, we recovered six Microbacterium from 624 samples, a little less than 1% of isolates. 9 In this study of diseased ears, Microbacterium species were recovered at a 10ϫ higher rate from infected ears.
2) The incidence of Microbacterium recovery is higher in the single isolate group, suggesting that it is a primary rather than a co-pathogen.
3) Analysis of treatment failure shows that Microbacterium are commonly the only recovered isolate both in treatment failures and in cases of reinfection.
With respect to these patterns, the Microbacterium species are different from other gram-positive organisms commonly regarded as "normal flora." Staphylococcus capitis and S. epidermidis, for example, are found more commonly in normal than in diseased ear canals, are less frequently isolated as a "single isolate" than as one of several isolates, and are not commonly recovered from treatment failures.
The recognition of the Microbacterium species as important pathogens increases the importance of the grampositive pathogens; they may, indeed, routinely account for more than one fourth of all bacterial etiologies. The innate resistance of Microbacterium species to both the aminoglycosides and the quinolones encourages the use of topical therapy. Topical therapy allows for the administration of high concentrations of antibiotics, which can overwhelm organisms with high MICs. A 0.2% solution of a topical antibiotic contains, for example, 2000 mg/mL of antibiotic, which exceeds by over 100-fold the tissue levels (2-10 mg/mL) than might be expected with systemic administration and, by several-fold, the end point MICs of all pretherapy isolates.
The low incidence of fungal organisms should be noted. Despite a dearth of subjects from the Midwest, the geographic representation of pretherapy isolates is inclusive of all major climate zones. Both northern and southern states are well represented (Fig. 1 ). There were no significant regional fluctuations in the recovery rate of fungal organisms. Fungal organisms were not recovered in a higher frequency in some parts of the country as opposed to others. AOE everywhere is a bacterial disease. Percent of subjects with P. aeruginosa 52% 60% 55% 48% 50% 51% 32% 47%
